Linda M. Robertson
General Counsel bei Kanisa Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Linda M. Robertson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 13 | |
Kanisa Pharmaceuticals, Inc.
 Kanisa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kanisa Pharmaceuticals, Inc. develops pharmaceuticals and provides medical services. The company develops drugs for diagnosis and treatment of cancer. It was founded by David A. Socks and is located in San Diego, CA.
9
| Private Company | Pharmaceuticals: Major | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Linda M. Robertson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Medical Specialties | Chief Executive Officer Chief Operating Officer Sales & Marketing | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| MEDISTEM INC | Medical Specialties | Chief Executive Officer | |
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
LMS Medical Systems Ltd
 LMS Medical Systems Ltd Packaged SoftwareTechnology Services Part of Halma Plc, LMS Medical Systems Ltd develops monitoring software for medical uses. The company is based in Montréal, Canada. The Canadian company was founded by James W. G. Turner. LMS Medical Systems was acquired by Maclos Capital, Inc. on April 01, 2004. | Packaged Software | Director/Board Member | |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Founder | |
| CAREFUSION CORPORATION | Medical Distributors | Corporate Officer/Principal | |
Batu Biologics, Inc.
 Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman | |
| Stanford University | College/University | Doctorate Degree Masters Business Admin Corporate Officer/Principal | |
Mallinckrodt Medical, Inc.
 Mallinckrodt Medical, Inc. Medical SpecialtiesHealth Technology Mallinckrodt Medical, Inc. manufactures and markets healthcare products. Its products include contrast media & delivery systems, radiology imaging products, radiopharmaceuticals and urology imaging systems. The company is headquartered in Pointe-Claire, Canada. | Medical Specialties | Corporate Officer/Principal | |
GrowthWorks Capital Ltd.
 GrowthWorks Capital Ltd. Investment ManagersFinance GrowthWorks Capital Ltd. (GrowthWorks) is a venture capital firm founded in 1992 by David Levi. The firm is headquartered in Vancouver, Columbia with additionaal offices in Saskatchewan, Manitoba, New Brunswick, Newfoundland, Nova Scotia, and Ontario. | Investment Managers | Private Equity Investor | |
| DEXCOM, INC. | Medical Specialties | Founder Chief Operating Officer | |
Scancell Ltd.
 Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| Yale University | College/University | Corporate Officer/Principal | |
| Roanoke College | College/University | Undergraduate Degree | |
| University of Guelph | College/University | Undergraduate Degree | |
| University of Toronto | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| McMaster University | College/University | Masters Business Admin | |
| Virginia Polytechnic Institute & State University | College/University | Masters Business Admin | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Director/Board Member | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| EXAGEN INC. | Medical/Nursing Services | Chief Executive Officer Director/Board Member | |
Windamere Venture Partners LLC
 Windamere Venture Partners LLC Investment ManagersFinance Windamere Venture Partners LLC (Windamere Venture Partners) is an independent venture capital firm founded in 1999 by Scott L. Glenn. The firm is headquartered in San Diego. | Investment Managers | Chief Investment Officer Private Equity Analyst | |
Technology Alliance
 Technology Alliance Miscellaneous Commercial ServicesCommercial Services Technology Alliance supports and promotes technology-based businesses and research institutions. It organizes programs, events, data analysis, and policy activities for education, research, and entrepreneurship technology advancement. The company was founded by William H. Gates Sr. in 1996 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member | |
| Washington Biotechnology & Biomedical Association | Director/Board Member Chairman | ||
| SCANCELL HOLDINGS PLC | Biotechnology | Director/Board Member | |
Arzeda Corp.
 Arzeda Corp. BiotechnologyHealth Technology Arzeda Corp. operates as a synthetic biology company. It works thru agriculture, functionalized sweeteners and ingredients, chemicals and materials, and pharmaceuticals and diagnostics. The company was founded by Eric Althoff, David Baker, Daniela Grabs-R?thlisberger, Michael A. Martino and Alexandre Zanghellini in 2008 and is headquartered in Seattle, WA. | Biotechnology | Founder | |
Targazyme, Inc.
 Targazyme, Inc. BiotechnologyHealth Technology Targazyme, Inc. operates as a biotechnology company. It develops and commercializes breakthrough products. The firm offers products for stem cell transplantation, immunotherapy for cancer, regenerative medicine, and gene therapy. The company was founded by Lynnet Koh and is headquartered in Carlsbad, CA. | Biotechnology | Director/Board Member | |
| AMPIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Wyeth Laboratories, Inc. | Corporate Officer/Principal | ||
Cellastra, Inc.
 Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Capella Therapeutics, Inc.
 Capella Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capella Therapeutics, Inc. develops small molecule drugs to treat cancer and inflammatory diseases. The private company is based in San Diego, CA. The company was founded in 2014 by Yun Long. Yun Long has been the CEO since 2014. | Miscellaneous Commercial Services | Director/Board Member | |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Signal Therapeutics, Inc. | Chief Executive Officer | ||
Habit DX, Inc.
 Habit DX, Inc. Medical SpecialtiesHealth Technology Habit DX, Inc. manufactures clinical measuring and monitoring tools. The private company is based in San Francisco, CA. | Medical Specialties | Director/Board Member | |
Excision BioTherapeutics, Inc.
 Excision BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Excision BioTherapeutics, Inc. develops gene editing therapeutics for the treatment of life-threatening disease caused by viral infections. The firm focuses on Human Immunodeficiency Virus -1 therapeutics, JC Virus and Progressive Multifocal Leukoencephalopathy, Hepatitis B virus therapeutics, and CRISPR vaccinations?. The company was founded by David Rowe, Kamel Khalili, Thomas Malcolm, and Rob Simmons in 2015 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
NeuraMetrix, Inc.
 NeuraMetrix, Inc. Electronic Equipment/InstrumentsElectronic Technology NeuraMetrix, Inc. manufactures clinical measurement tools for monitoring brain health. The company was founded by Jan Samzelius and Christian Olsson in 2012 and is headquartered in Palo Alto, CA. | Electronic Equipment/Instruments | Chairman | |
| PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
HemaFlo Therapeutics, Inc.
 HemaFlo Therapeutics, Inc. BiotechnologyHealth Technology HemaFlo Therapeutics, Inc. is an American private company that develops drag-reducing polymers (DRP) to improve blood flow in acute and chronic conditions associated with decreased tissue perfusion. DRPs are administered intravenously and work mechanically to reduce friction in flowing blood and stimulate blood vessel dilation, resulting in improved blood flow without increasing blood pressure. The CEO of the company is Michael A. Martino. | Biotechnology | Chief Executive Officer | |
| CaraVan Biologix | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 41 |
| Kanada | 9 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 3 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 148 |
| Corporate Officer/Principal | 52 |
| Independent Dir/Board Member | 36 |
| Chief Executive Officer | 32 |
| Chairman | 32 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Arnold Lewis Oronsky | 35 |
| Alan J. Lewis | 33 |
| Scott Glenn | 28 |
| Faheem Hasnain | 27 |
| Wendell Wierenga | 23 |
| M. Scott Salka | 20 |
| Saiid Zarrabian | 18 |
| Alan Fuhrman | 17 |
| Joe Regan | 17 |
| Michael Martino | 14 |
| Sigrid van Bladel | 13 |
| Nicholas Lydon | 13 |
| Robert Corringham | 12 |
| Michael J. Walsh | 11 |
| Isai Peimer | 10 |
- Börse
- Insiders
- Linda M. Robertson
- Unternehmensverbindungen
